The activation NF-κB signaling pathway is associated with the PI3K/AKT signal pathway in insulin resistance and pancreatic beta cell dysfunction in metabolic syndrome (Malle et al., 2015; Sabir et al., 2019; Capece et al., 2022). Here, AKT1 is linked to metabolic syndrome.